Preliminary Programme
(Subject to Changes)

Thursday, November 18

18:00-19:30 Opening Ceremony
Greetings
Keynote Lecture

19:30-21:00 Welcome Reception

 
 
 
 
Friday, November 19

08:00-09:30 Plenary Session 1: Fixed Dose Combination Therapy in Diabesity
Chairs: John Prins
(Australia)
TBA

Fixed Dose Combination in Diabetes: Should We Be Only Concerned about Sugar?,
John Prins (Australia)
Can we use FDC to get to target more easily?, Tim Davis (Australia)
Therapeutic Strategies for the Cardiovascular Complications of Diabesity? TBA

09:30-11:00 Free Communications 1
Chairs:
Ian Hamilton-Craig (Australia)
Michael Stowasser (Australia)

11:00-11:30 Coffee Break, Exhibition Visit & Poster View

11:30-13:00 Plenary Session 2: Fixed Dose Combination Therapy in Hypertension
Chairs: Henry Krum (Australia)
Suzanne Oparil (USA)

Fixed Dose Combination Therapy with Renin Inhibitors, Henry Krum (Australia)
Treatment Resistant Hypertension, Suzanne Oparil (USA)
Combination Therapy to Target Central Blood Pressure, James Sharman (Australia)

13:00-14:30 Lunch (Exhibition Area)

14:30-16:00 Plenary Session 3: Pharmacoeconomics of Combination Therapy
Chairs: Laurie Howes 
(Australia)
Danny Liew 
(Australia)

Overview of Pharmacoeconomics, Danny Liew (Australia)
Regulatory Persectives of FDCT, Laurie Howes (Australia)
Healtheconomic Considerations of FDCT, Dan Tucker (Australia)

16:00-16:30 Coffee Break, Exhibition Visit & Poster View

16:30-18:00 Plenary Session 4: Fixed Dose Combination Varia
Chairs: Atifur Rahman (Australia)
Nathalie Van Havre (Australia)

Fixed Dose Combination for Blood Pressure and Lipids, Karam Kostner (Australia)
Anti Platelet Fixed Dose Combination, Atifur Rahman (Australia)
Fixed Dose Combination for Diabetes and Hypertension, Nathalie Van Havre (Australia)

20:00-22:00 Presidential Dinner (Optional)

 
 
 
 
Saturday, November 20

08:00-09:30 Plenary Session 5: Fixed Dose Combination Therapy in Hyperlipidemia
Chairs:
Gerhard M. Kostner (Austria)
David Sullivan (Australia)

Combination Therapy in Hyperlipidemia: What Do We Need?, Gerald Watts (Australia)
Fixed Dose Combination with Niacin: As Good as it Gets?, Soneil Gupta (India)
Statin Fibrate Fixed Dose Combination: Lessons from ACCORD, I. Hamilton-Craig (Australia)

09:30-11:00 Free Communications 2
Chairs:
Eduardo Pimenta (Australia)
James Sharman (Australia)

11:00-11:30 Coffee Break, Exhibition Visit & Poster View

11:30-13:00 Plenary Session 6: Fixed Dose Combination Therapy: Hypertension
Chairs: Leonrad Arnolda
(Australia)
Suzanne Oparil (USA)

The History of Combination Therapy, Suzanne Oparil (USA)
Risks and Challenges with Fixed Dose Combination Therapy, Leonard Arnolda (Australia)
Is There a Preferred Combination?, TBA

13:00-14:30 Lunch (Exhibition Area) 

13:30-14:30 Lunchtime Symposium sponsored by msd_logo_colour

14:30-16:00 Plenary Session 7: Future of Fixed Dose Combination Therapy: Roundtable
Chairs: Karam Kostner
(Australia)
Eduardo Pimenta (Australia)
Gerald Watts (Australia)

Hypertension, Eduardo Pimenta
Lipids, Karam Kostner
Diabetes, Gerald Watts

16:00-16:30 Closing Ceremony

16:30-17:00 Coffee to go, Exhibition Visit & Poster View

 

Join Us to Receive Free Updates







binary options trading binary options trading binary options binary options finance